Notice to sell 5,000 Ameriprise shares filed

Ameriprise Financial has a notice under Rule 144 for a planned sale of 5,000 shares of its common stock.

Rhea-AI Filing Summary

Ameriprise Financial has a notice under Rule 144 for a planned sale of 5,000 shares of its common stock. The shares are to be sold through American Enterprise Investment Services, Inc. on the NYSE at an aggregate market value of 2,660,400.

The 5,000 shares were acquired on 02/10/2025 through the vesting of compensatory equity awards, with payment described as compensatory equity awards on that same date. The approximate date of sale listed is 02/10/2026, and 92,905,713 shares of common stock were outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Ameriprise (AMP) Form 144 filing disclose?

The Form 144 discloses a planned sale of 5,000 shares of Ameriprise Financial common stock. The shares are to be sold on the NYSE through American Enterprise Investment Services at an aggregate market value of 2,660,400, subject to Rule 144 conditions.

How many Ameriprise (AMP) shares are planned for sale under this Form 144?

The filing covers a planned sale of 5,000 shares of Ameriprise Financial common stock. These shares were acquired through vesting of compensatory equity awards and are listed with an aggregate market value of 2,660,400 for an approximate sale date of 02/10/2026.

How were the Ameriprise (AMP) shares in this Form 144 acquired?

The 5,000 Ameriprise Financial shares were acquired on 02/10/2025 via vesting of compensatory equity awards. The nature of payment is described as compensatory equity awards on that same date, indicating the securities came from equity-based compensation rather than a cash purchase.

When does the Ameriprise (AMP) Form 144 indicate the shares may be sold?

The Form 144 lists an approximate date of sale of 02/10/2026 for the 5,000 Ameriprise Financial shares. This date is an estimate for when the seller may begin sales of the restricted securities on the NYSE, in compliance with Rule 144 requirements.

What is the aggregate market value of Ameriprise (AMP) shares in this Form 144?

The planned sale of 5,000 Ameriprise Financial common shares is shown with an aggregate market value of 2,660,400. This value reflects the market-based valuation used in the notice of proposed sale under Rule 144, tied to the NYSE listing.

How many Ameriprise (AMP) shares were outstanding according to this Form 144?

The Form 144 states that 92,905,713 Ameriprise Financial common shares were outstanding. This figure provides context for the relative size of the proposed 5,000-share sale, which represents only a small portion of the total outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 06:33 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001282835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMERIPRISE FINANCIAL INC.
SEC File Number	001-32525
Address of Issuer	901 THIRD AVENUE SOUTH MINNEAPOLIS MINNESOTA 55402
Phone	612-671-3000
Name of Person for Whose Account the Securities are To Be Sold	William Fredrick Truscott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	American Enterprise Investment Services, Inc. 1350 Ameriprise Financial Center Minneapolis MN 55474	5000	2660400	92905713	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/2025	Vesting of Compensatory Equity Awards - See Remarks	Amerprise Financial, Inc.			5000	02/10/2025	Compensatory Equity Awards

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares were acquired through various compensatory awards more than a year ago. Shares were sold for the account of the Filer's limited liability company.
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wendy B. Mahling for William Fredrick Truscott
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)